In ChD CA patients (vs. NH controls), we observed 79% (p < 0.001) and 49.6% (p < 0.05) decline in the ACTG and FLNA protein levels, respectively (Figures 4A,B). The gene discussed is ACTG1; the disease is coronary artery disorder.